Congratulations to AMC Health, a longstanding client of GT, for securing a strategic growth investment from York Private Equity, the private investing arm of York Capital Management.
AMC Health is
Continue Reading GT Telehealth Client Secures Strategic Growth Investment
Congratulations to our client Venn, an Israeli PropTech company active in the US and Europe, on successfully completing a $60 million Series B funding round. Founded in 2017, Venn currently
Continue Reading Venn Completes $60 Million in Series B Funding
Greenberg Traurig’s cross-border team represented Volvo AB (“Volvo”), the corporate investment arm of the Swedish luxury automobile marque, as part of its $3 million investment into Driivz Ltd. Driivz is
Continue Reading GT Team Represents Volvo in Israel-Based Investment
On Jan. 13, 2020, the Committee on Foreign Investment in the United States (CFIUS) released two long-awaited sets of final regulations that implement nearly all of the Foreign Investment Risk
Continue Reading CFIUS Issues Final Regulations on National Security Review of Foreign Investments in the United States under FIRRMA: Broader Reach, Mandatory Filings, and Limited Exceptions
The Foreign Investment in Real Property Tax Act of 1980, as amended (FIRPTA), imposes tax on gain realized on disposition by nonresident alien individuals or foreign corporations (non-U.S. persons) of
Continue Reading Proposed Regulations for Qualified Foreign Pension Funds that are Exempt from U.S. Tax on Disposition of U.S. Real Property Interests
Earlier this summer, S&P Global gave the Israeli economy a vote of confidence by upgrading Israel’s credit rating for the first time in seven years. As reported in a Calcalist
Continue Reading Israel’s Economy Continues to Outperform
Section 338(h)(10) of the Internal Revenue Code can provide significant tax benefits to a buyer of 80% or more of a target corporation. A 338(h)(10) election allows a buyer of
Continue Reading GT’s Quick Guide to Section 338(h)(10) Elections
On June 6, the Boston office of Greenberg Traurig hosted the Wharton Israel Conference “Spotlight on Israeli Innovation in Healthcare and Biopharmaceuticals” for Boston area biotechnology and pharmaceutical professionals with
Continue Reading Greenberg Traurig Hosts Wharton Israel Conference Monday, June 6, 2016
Despite the close US-Israel relationship, Israeli companies and funds seeking to invest in US technologies can face US national security scrutiny that could significantly delay deals, and in some cases
Continue Reading How Israeli entities can plan for US security review and reduce risk when investing in US technology companies
Greenberg Traurig will be sponsoring two major Israel events this coming week.
The first is the OurCrowd Global Investor Summit (January 25-26), set to bring together 3,000 investors and companies
Continue Reading Greenberg Traurig to Sponsor Two Major Israel Event